Last reviewed · How we verify
NCT05532592
Investigation on the Hesitancy of COVID-19 Vaccination Among Liver Transplant Recipients in China
trial testing Perceptions and attitudes towards COVID-19 and COVID-19 vaccine in Vaccine Hesitancy in 449 participants. Completed in 30 May 2022.
10 May 2022
Quick facts
| Lead sponsor | RenJi Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 449 |
| Start date | 27 April 2022 |
| Primary completion | 10 May 2022 |
| Estimated completion | 30 May 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Perceptions and attitudes towards COVID-19 and COVID-19 vaccine
Conditions studied
- Vaccine Hesitancy — all drugs for Vaccine Hesitancy →
Sponsor
RenJi Hospital
Who can join
18 and older, any sex, with Vaccine Hesitancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
On WeChat platform, through a point-to-point connection, and carry on the questionnaire survey to collect information of liver transplant recipients followed-up by the department of Liver Surgery, Renji Hospital Shanghai Jiao Tong University. Patients meeting inclusion and exclusion criteria will be selected. Conduct statistical analysis to describe the incidence of adverse reactions related to COVID-19 vaccine after liver transplantation, and to compare and evaluate the factors leading to COVID-19 vaccine hesitancy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Investigation on the hesitancy of COVID-19 vaccination among liver transplant recipients: A cross-sectional study in China.
Pan Y, Gong S, Zhu X, Xue C, et al · · 2022 · cited 5× · PMID 36589975 · DOI 10.3389/fpubh.2022.1014942
Verify or expand the search:
- PubMed search for NCT05532592
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vaccine Hesitancy
Currently open trials in the same condition.
- NCT06988969 — Predicting Vaccine Hesitancy Using Machine Learning · active not recruiting
- NCT06513494 — Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial · NA · recruiting
- NCT06237374 — Supporting CHWs as Vaccine Educators: Impact of a Digital Training and Chatbot Intervention on Vaccination in Kenya · NA · active not recruiting
- NCT05910879 — RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos) · NA · active not recruiting
Other RenJi Hospital trials
Trials by the same sponsor.
- NCT07584733 — Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper · Phase 2 · not yet recruiting
- NCT07537725 — EEG-TMS for Postoperative Delirium After Cardiac Surgery · NA · not yet recruiting
- NCT07527936 — A Study of BEN301 Injection in theTreatment of Autoimmune Diseases · EARLY_PHASE1 · not yet recruiting
- NCT07343076 — Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE · NA · not yet recruiting
- NCT07449793 — Biochemical Response and Clinical Outcomes in Patients With PBC · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05532592 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RenJi Hospital
- Last refreshed: 8 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05532592.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing